References
[1] Gaetano C, Stefania D, Giuseppe R, Giovanni C, Nicola M, et al.
Frequency of Surgery Among Children Who Have Adenotonsillar Hypertrophy
and Improve After Treatment With Nasal Beclomethasone. Pediatrics 2003,
111: 236-238.
[2] Akcay A, Kara CO, Dagdeviren E, and Zencir M. Variation in
tonsil size in 4- to 17-year-old schoolchildren. Journal of
Otolaryngology 2006, 35: 270-274.
[3] Saedi B, Sadeghi M, Mojtahed M, and Mahboubi H. Diagnostic
efficacy of different methods in the assessment of adenoid hypertrophy.
American Journal of Otolaryngology 2011, 32: 147-151.
[4] Ras AE, Hamed MH, and Abdelalim AA. Montelukast combined with
intranasal mometasone furoate versus intranasal mometasone furoate; a
comparative study in treatment of adenoid hypertrophy. Am J Otolaryngol
2020, 41: 102723.
[5] Cheng L, Chen J, Fu Q, He S, Li H, et al. Chinese Society of
Allergy Guidelines for Diagnosis and Treatment of Allergic Rhinitis.
Allergy, asthma & immunology research 2018, 10: 300-353.
[6] Bousquet J, Hellings PW, Agache I, Amat F, Annesi-Maesano I, et
al. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018):
Change management in allergic rhinitis and asthma multimorbidity using
mobile technology. J Allergy Clin Immunol 2019, 143: 864-879.
[7] Cassano P, Gelardi M, Cassano M, Fiorella ML, Fiorella R.
Adenoid tissue rhinopharyngeal obstruction grading based on
fiberendoscopic findings: a novel approach to therapeutic management.
Int J Pediatr Otorhinolaryngol 2003, 67:1303–1309.
[8] Cho KS, Kim SH, Hong SL, Lee J, Mun SJ, et al. Local Atopy in
Childhood Adenotonsillar Hypertrophy. American journal of rhinology &
allergy 2018, 32: 160-166.
[9] Muhammed FE, Mahmut Dogru, Ahmet AC, and Merve LN. Adenoid
hypertrophy in children with allergic disease and influential factors.
International journal of pediatric otorhinolaryngology 2015, 79:
694-697.
[10] Mygind N, Nielsen LP, Hoffmann HJ, Shukla A, Blumberga G, et
al. Mode of action of intranasal corticosteroids. Journal of Allergy &
Clinical Immunology 2001, 108: S16-S25.
[11] Shokouhi F, Jahromi AM, Majidi MR, and Salehi M. Montelukast in
Adenoid Hypertrophy: Its Effect on Size and Symptoms. Iranian Journal of
Otorhinolaryngology 2015, 27: 443-448.
[12] Dayyat E, Serpero LD, Kheirandish-Gozal L, Goldman JL, and
Gozal D. Leukotriene Pathways and In Vitro Adenotonsillar Cell
Proliferation in Children With Obstructive Sleep Apnea. Chest 2009, 135:
1142-1149.
[13] Paulucci BP, Pereira J, Picciarelli P, Levy D, and Di Francesco
RC. Expression of cysteinyl leukotriene receptor 1 and 2 (CysLTR1 and
CysLTR2) in the lymphocytes of hyperplastic tonsils: comparison between
allergic and nonallergic snoring children. International Forum of
Allergy & Rhinology 2016, 6: 1151-1158.
[14] Goldbart AD, Greenberg-Dotan S, and Tal A. Montelukast for
Children With Obstructive Sleep Apnea: A Double-blind,
Placebo-Controlled Study. Pediatrics 2012, 130: e575-580.